Lars Fruergaard Jørgensen, Novo Nordisk CEO (Christopher Goodney/Bloomberg via Getty Images)

No­vo Nordisk drops two pro­grams as it plots We­govy come­back

Two No­vo Nordisk pro­grams in obe­si­ty and car­dio­vas­cu­lar dis­ease are on the chop­ping block, the com­pa­ny buried in its Q3 re­port, as CEO Lars Fruer­gaard …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.